GOALS & OBJECTIVES
Blood Conservation and Chemotherapy-Induced Anemia: From Evidence-Based Guidelines to Clinical Practice
The contents of this issue of Johns Hopkins Advanced Studies in Medicine and University of Tennessee Advanced Studies in Pharmacy include 4 review articles.
Activity Date: September 2008  — Activity Info: Volume8, (10)
Goals & Objectives | Faculty | Complete Pre-Test Activity | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 

GOAL
To provide oncologists, hematologists, oncology surgeons, and hospital pharmacists with up-to-date information on blood conservation and chemotherapy-induced anemia.

TARGET AUDIENCE
This activity is designed for oncologists, hematologists, oncology surgeons, and hospital pharmacists. No prerequisites required.

LEARNING OBJECTIVES
At the conclusion of this activity, the participant should be able to:

  • Discuss current treatment strategies for managing patients with chemotherapy-induced anemia (CIA).
  • Identify patients with CIA at risk for blood transfusion.
  • Describe the benefits and risks of blood transfusion on patient outcomes.
  • Develop effective blood conservation strategies for patients with CIA.

The Johns Hopkins University School of Medicine and The University of Tennessee College of Pharmacy take responsibility for the content, quality, and scientific integrity of this CE activity.

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The Johns Hopkins University School of Medicine and The University of Tennessee College of Pharmacy (UTCOP). The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The UTCOP is accredited by the Accreditation Council of Pharmacy Education (ACPE) to provide continuing education for pharmacists.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This knowledge-based program is sponsored by The University of Tennessee College of Pharmacy who is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this program will provide 2 contact hours credit (0.2 CEUs). A statement of CE credit will be available online immediately following successful completion of the program. ACPE program #064-000-08-208-H01-P.

This continuing education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean of Continuing Pharmacy Education, University of Tennessee College of Pharmacy.

The estimated time to complete this educational activity: 2 hours. After reading this monograph, participants may receive credit by completing the CE test, evaluation, and receiving a score of 70% or higher.

Release date: September 15, 2008. Expiration date: September 15, 2010.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine and The University of Tennessee College of Pharmacy names implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

This activity is supported by an educational grant from Ortho Biotech.

     
Home | Contact Us | View Account | Need Help?